LINCOCIN (lincomycin injection, USP) is available as a sterile, clear, and colorless solution in the following strength and package sizes:
| Unit of Sale | Concentration |
|---|---|
NDC 0009-0555-01 or NDC 0009-0104-04 | 600 mg/2 mL |
2 mL multiple-dose vial | (300 mg/mL) |
NDC 0009-0107-04 | 3,000 mg/10 mL |
10 mL multiple-dose vial | (300 mg/mL) |
Each mL of LINCOCIN contains 300 mg lincomycin (equivalent to 340 mg lincomycin hydrochloride, USP); also benzyl alcohol, 9.45 mg added as preservative.
LINCOCIN (lincomycin injection, USP) is available as a sterile, clear, and colorless solution in the following strength and package sizes:
| Unit of Sale | Concentration |
|---|---|
NDC 0009-0555-01 or NDC 0009-0104-04 | 600 mg/2 mL |
2 mL multiple-dose vial | (300 mg/mL) |
NDC 0009-0107-04 | 3,000 mg/10 mL |
10 mL multiple-dose vial | (300 mg/mL) |
Each mL of LINCOCIN contains 300 mg lincomycin (equivalent to 340 mg lincomycin hydrochloride, USP); also benzyl alcohol, 9.45 mg added as preservative.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.